Clinical Trial Update: HEPSERA Post Marketing Surveillance

View source ↗

Summary

A post-marketing surveillance study of HEPSERA (adefovir dipivoxil) for hepatitis B has completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepsera (adefovir dipivoxil)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Status: COMPLETED | Results posted: 2011-04-05